Desmin ensheathment ratio as an indicator of vessel stability: evidence in normal development and in retinopathy of prematurity.
We developed a measure of pericyte/endothelial interaction, the desmin ensheathment ratio (DER), using the intermediate filament desmin as an indicator of pericyte ensheathment and have examined the DER in normal retinal vascular development and in the kitten retinopathy of prematurity (ROP) model. We also examined the role of mural cells in the pathogenesis of ROP. Postnatal day 1 to 45 kitten retinae were labeled for desmin, alpha-smooth muscle actin (SMA), and isolectin-B4. Newborn kittens exposed to hyperoxia and then returned to room air for 0 to 40 days (dRA) were similarly labeled. The ratio of desmin to lectin labeling on confocal images yielded the DER. Ultrastructural studies showed that mural cells were present on even the most primitive vessels. During normal development, immature vascular beds had DERs of 0.3 to 0.6 whereas mature beds, which predominated by postnatal day 28, had DERs greater than 0.9. Immature pericytes and smooth muscle cells did not prevent hyperoxia-induced vessel regression. During the vasoproliferative stage of ROP, the DERs of intra- and preretinal vessels ranged between 0.2 and 0.5. In the recovery stage, the DER increased in parallel with regression of pathology, reaching 0.9 at 34 dRA. Stabilization of the DER by the fifth postnatal week was temporally coincident with the development of resistance to hyperoxia-induced vessel regression previously reported in the kitten. These observations lead us to suggest that a DER of 0.9 represents a vascular stability threshold and that a low DER observed during ROP raises the possibility that mural cell abnormalities play a key role in the pathogenesis of ROP.
Chan-Ling
Tailoi
T
Department of Anatomy, Institute for Biomedical Research, University of Sydney, Sydney, NSW 2006, Australia. tailoi@anatomy.usyd.edu.au.
Page
Matthew Philip
MP
Gardiner
Tom
T
Baxter
Louise
L
Rosinova
Emilia
E
Hughes
Suzanne
S
D000199:Actins / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn; D001808:Blood Vessels / Q000166:cytology* / Q000254:growth & development / Q000648:ultrastructure; D002415:Cats; D002450:Cell Communication / Q000502:physiology; D003893:Desmin / Q000378:metabolism*; D004195:Disease Models, Animal; D042783:Endothelial Cells / Q000378:metabolism; D006801:Humans; D018496:Hyperoxia / Q000150:complications; D007150:Immunohistochemistry; D007231:Infant, Newborn; D037102:Lectins / Q000378:metabolism; D018613:Microscopy, Confocal; D032389:Myocytes, Smooth Muscle / Q000378:metabolism; D020286:Pericytes / Q000378:metabolism; D012160:Retina / Q000166:cytology* / Q000254:growth & development*; D012171:Retinal Vessels / Q000166:cytology*; D012178:Retinopathy of Prematurity / Q000209:etiology / Q000473:pathology*
D000199:Actins; D003893:Desmin; D037102:Lectins